These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25609990)

  • 1. Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis.
    Kostev K; Dippel FW; Rathmann W
    Diabetes Metab Syndr Obes; 2015; 8():45-8. PubMed ID: 25609990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care.
    Kostev K; Dippel FW; Rathmann W
    Prim Care Diabetes; 2016 Apr; 10(2):142-7. PubMed ID: 26324105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care.
    Pscherer S; Kostev K; Dippel FW; Rathmann W
    Diabetes Metab Syndr Obes; 2016; 9():17-23. PubMed ID: 26929655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for achieving target glycemic control in Japanese patients with type 2 diabetes after initiation of basal supported oral therapy using insulin glargine: sub-analysis of the ALOHA2 study, drug use surveillance in Japan.
    Ikeda Y; Tsukube S; Kadowaki T; Odawara M
    Diabetol Int; 2016 Jun; 7(2):188-198. PubMed ID: 30603263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment persistence in the use of basal insulins in Poland and Germany
.
    Rathmann W; Czech M; Franek E; Kostev K
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response.
    Gu T; Hong T; Zhang P; Tang S; Bi Y; Lu H; Men L; Ma D; Zhu D
    Diabetes Ther; 2018 Apr; 9(2):771-787. PubMed ID: 29524190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
    Blonde L; Meneghini L; Peng XV; Boss A; Rhee K; Shaunik A; Kumar S; Balodi S; Brulle-Wohlhueter C; McCrimmon RJ
    Diabetes Ther; 2018 Jun; 9(3):1347-1358. PubMed ID: 29600507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry.
    Ji L; Tsai ST; Lin J; Bhambani S
    Diabetes Ther; 2015 Dec; 6(4):519-530. PubMed ID: 26494149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
    JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study.
    Curtis B; Lage MJ
    J Med Econ; 2014 Jan; 17(1):21-31. PubMed ID: 24195723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison on efficacy and safety of two regimens for treatment of type 2 diabetes mellitus: glargine plus metformin versus neutral protamine hagedorn plus metformin].
    Hu M; Luo Y; Zhang L; Yang X; Zhang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):622-5. PubMed ID: 20649032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care provider management of patients with type 2 diabetes mellitus: analysis of trends in attitudes and practices.
    Williamson C; Glauser TA; Burton BS; Schneider D; Dubois AM; Patel D
    Postgrad Med; 2014 May; 126(3):145-60. PubMed ID: 24918800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.
    Rhoads GG; Kosiborod M; Nesto RW; Fonseca VA; Lu SE; Zhang Q; Foody JM
    Am J Cardiol; 2009 Oct; 104(7):910-6. PubMed ID: 19766755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo
    Wiesli P; Schories M
    Diabetes Ther; 2018 Dec; 9(6):2325-2334. PubMed ID: 30302721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.